Ariunzaya Bat‐Erdene

The Roles of ROS Generation in RANKL-Induced Osteoclastogenesis: Suppressive Effects of Febuxostat

Mohannad Ashtar, Hirofumi Tenshin, Jumpei Teramachi et al. · Cancers · 2020 · 40 citations · Full text

Medicine, Oncology, Pharmacology +15

TAK1 is a pivotal therapeutic target for tumor progression and bone destruction in myeloma

Jumpei Teramachi, Hirofumi Tenshin, Masahiro Hiasa et al. · Haematologica · 2020 · 30 citations · Full text

Medicine, Cell Biology, Oncology +17

PD-L1 upregulation in myeloma cells by panobinostat in combination with interferon-γ

Masami Iwasa, Takeshi Harada, Asuka Oda et al. · Oncotarget · 2019 · 28 citations · Full text

Life Sciences, Immunology, Oncology +17

Synergistic targeting of Sp1, a critical transcription factor for myeloma cell growth and survival, by panobinostat and proteasome inhibitors

Ariunzaya Bat‐Erdene, Hirokazu Miki, Asuko Oda et al. · Oncotarget · 2016 · 20 citations · Full text

Medicine, Oncology, Pharmacology +17

Unique anti‐myeloma activity by thiazolidine‐2,4‐dione compounds with Pim inhibiting activity

Shiro Fujii, Shingen Nakamura, Asuka Oda et al. · British Journal of Haematology · 2018 · 20 citations · Full text

Medicine, Oncology, Pharmacology +13